IP Library › Granted Patent US 12,252,533
Granted Patent B2
US 12,252,533 · App. 18/069,838 · Granted Mar 18, 2025

Anti-transferrin receptor antibodies with tailored affinity

Inventors: Stefan Dengl (Munich, DE); Guy Georges (Habach, DE); Ulrich Goepfert (Penzberg, DE); Jens Niewoehner (Munich, DE); Tilman Schlothauer (Penzberg, DE)
Assignee: Hoffmann-La Roche Inc.
C07K16/28A61K39/3955C07K14/79C07K16/2881A61P25/00C07K2317/24C07K2317/31C07K2317/33C07K2317/56C07K2317/626C07K2317/75C07K2317/76
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,252,533
App. No.
18/069,838
Granted
Mar 18, 2025
Kind
B2
Abstract

Herein is reported an anti-transferrin receptor antibody that specifically binds to human transferrin receptor and cynomolgus transferrin receptor, which comprises i) a humanized heavy chain variable domain derived from the heavy chain variable domain of SEQ ID NO: 01, and ii) a humanized light chain variable domain derived from the light chain variable domain of SEQ ID NO: 26, wherein the antibody has an off-rate for the human transferrin receptor that is equal to or less than (i.e. at most) the off-rate of the anti-transferrin receptor antibody 128.1 for the cynomolgus transferrin receptor, whereby the off-rates are determined by surface plasmon resonance, and whereby the anti-transferrin receptor antibody 128.1 has a heavy chain variable domain of SEQ ID NO: 64 and a light chain variable domain of SEQ ID NO: 65.

Claims (46)

1. A humanized antibody that specifically binds to human transferrin receptor (TfR), wherein the antibody comprises

in the heavy chain variable domain the hypervariable regions (HVRs) of SEQ ID NOs: 66, 68 and 71, and

in the light chain variable domain the HVRs of SEQ ID NOs: 75, 76 and 78.

2. The humanized antibody according to claim 1 , comprising a heavy chain variable domain of SEQ ID NO: 23 and a light chain variable domain of SEQ ID NO: 37.

3. The humanized antibody according to claim 1 , wherein the humanized antibody specifically binds to human transferrin receptor and to cynomolgus transferrin receptor.

4. The humanized antibody according to claim 1 , wherein the humanized antibody is a multispecific antibody having at least one binding specificity for the human transferrin receptor and at least one binding specificity for a therapeutic target.

5. The humanized antibody according to claim 4 , wherein the humanized antibody comprises a first antigen binding site which binds the human transferrin receptor and a second antigen binding site which binds a brain antigen.

6. The humanized antibody according to claim 5 , wherein the humanized antibody is a bispecific antibody comprising

i) a first binding site binding to human transferrin receptor and comprising a heavy chain variable domain of SEQ ID NO: 23 and a light chain variable domain of SEQ ID NO: 37,

and

ii) a second binding site

a) binding to Abeta and comprising a heavy chain variable domain of SEQ ID NO: 81 and a light chain variable domain of SEQ ID NO: 82, or

b) binding to alpha-synuclein and comprising a heavy chain variable domain of SEQ ID NO: 83 and a light chain variable domain of SEQ ID NO: 84, or

c) binding to alpha-synuclein and comprising a heavy chain variable domain of SEQ ID NO: 85 and a light chain variable domain of SEQ ID NO: 86, or

d) binding to alpha-synuclein and comprising a heavy chain variable domain of SEQ ID NO: 87 and a light chain variable domain of SEQ ID NO: 88, or

e) binding to alpha-synuclein and comprising a heavy chain variable domain of SEQ ID NO: 91 and a light chain variable domain of SEQ ID NO: 92, or

f) binding to alpha-synuclein and comprising a heavy chain variable domain of SEQ ID NO: 89 and a light chain variable domain of SEQ ID NO: 90, or

g) binding to alpha-synuclein and comprising a heavy chain variable domain of SEQ ID NO: 93 and a light chain variable domain of SEQ ID NO: 94, or

h) binding to CD20 and comprising a heavy chain variable domain of SEQ ID NO: 79 and a light chain variable domain of SEQ ID NO: 80.

7. The humanized antibody according to claim 1 , wherein the humanized antibody is

a) a full length antibody of the human subclass IgG1, or

b) a full length antibody of the human subclass IgG4, or

c) a full length antibody of the human subclass IgG1 with the mutations L234A, L235A and P329G,

d) a full length antibody of the human subclass IgG4 with the mutations S228P, L235E and optionally P329G,

e) a full length antibody of the human subclass IgG1 with the mutations L234A, L235A and P329G in both heavy chains and the mutations T366W and S354C in one heavy chain and the mutations T366S, L368A, Y407V and Y349C in the respective other heavy chain, or

f) a full length antibody of the human subclass IgG4 with the mutations S228P, L235E and optionally P329G in both heavy chains and the mutations T366W and S354C in one heavy chain and the mutations T366S, L368A, Y407V and Y349C in the respective other heavy chain.

8. The humanized antibody according to claim 1 , wherein the humanized antibody comprises

i) a homodimeric Fc-region of the human IgG1 subclass optionally with the mutations P329G, L234A and L235A, or

ii) a homodimeric Fc-region of the human IgG4 subclass optionally with the mutations P329G, S228P and L235E, or

iii) a heterodimeric Fc-region whereof

a) one Fc-region polypeptide comprises the mutation T366W, and the other Fc-region polypeptide comprises the mutations T366S, L368A and Y407V, or

b) one Fc-region polypeptide comprises the mutations T366W and Y349C, and the other Fc-region polypeptide comprises the mutations T366S, L368A, Y407V, and S354C, or

c) one Fc-region polypeptide comprises the mutations T366W and S354C, and the other Fc-region polypeptide comprises the mutations T366S, L368A, Y407V and Y349C,

or

iv) a heterodimeric Fc-region of the human IgG4 subclass whereof both Fc-region polypeptides comprise the mutations P329G, L234A and L235A and

a) one Fc-region polypeptide comprises the mutation T366W, and the other Fc-region polypeptide comprises the mutations T366S, L368A and Y407V, or

b) one Fc-region polypeptide comprises the mutations T366W and Y349C, and the other Fc-region polypeptide comprises the mutations T366S, L368A, Y407V, and S354C, or

c) one Fc-region polypeptide comprises the mutations T366W and S354C, and the other Fc-region polypeptide comprises the mutations T366S, L368A, Y407V and Y349C,

or

v) a heterodimeric Fc-region of the human IgG4 subclass whereof both Fc-region polypeptides comprise the mutations P329G, S228P and L235E and

a) one Fc-region polypeptide comprises the mutation T366W, and the other Fc-region polypeptide comprises the mutations T366S, L368A and Y407V, or

b) one Fc-region polypeptide comprises the mutations T366W and Y349C, and the other Fc-region polypeptide comprises the mutations T366S, L368A, Y407V, and S354C, or

c) one Fc-region polypeptide comprises the mutations T366W and S354C, and the other Fc-region polypeptide comprises the mutations T366S, L368A, Y407V and Y349C.

9. A pharmaceutical formulation comprising the humanized antibody according to claim 1 and a pharmaceutically acceptable carrier.

10. A pharmaceutical formulation comprising the humanized antibody according to claim 2 and a pharmaceutically acceptable carrier.

11. A pharmaceutical formulation comprising the humanized antibody according to claim 6 and a pharmaceutically acceptable carrier.

Priority Claims (2)
EP 15173508 · Jun 24, 2015 · regional
EP 15176084 · Jul 9, 2015 · regional
Continuity (4)
Continuation 16397227 · Apr 29, 2019
Continuation 15847448 · Dec 19, 2017
Continuation PCTEP2016064460 · Jun 22, 2016
Related Publication 20230220071A1 · Jul 13, 2023
References Cited (400)
US 3773919A · Boswell et al. · 1973 [cited by applicant]
US 4120649A · Schechter et al. · 1978 [cited by applicant]
US 4665077A · Stringfellow et al. · 1987 [cited by applicant]
US 4737456A · Weng et al. · 1988 [cited by applicant]
US 4816567A · Cabilly et al. · 1989 [cited by applicant]
US 4861579A · Meyer, Jr. et al. · 1989 [cited by applicant]
US 4892538A · Aebischer et al. · 1990 [cited by applicant]
US 5114721A · Cohen et al. · 1992 [cited by applicant]
US 5154924A · Friden · 1992 [cited by applicant]
US 5195317A · Nobue et al. · 1993 [cited by applicant]
US 5208020A · Chari et al. · 1993 [cited by applicant]
US 5231000A · Majocha et al. · 1993 [cited by applicant]
US 5283187A · Aebischer et al. · 1994 [cited by applicant]
US 5416064A · Chari et al. · 1995 [cited by applicant]
US 5427927A · Meyer et al. · 1995 [cited by applicant]
US 5500362A · Robinson et al. · 1996 [cited by applicant]
US 5595721A · Kaminski et al. · 1997 [cited by applicant]
US 5624821A · Winter et al. · 1997 [cited by applicant]
US 5635483A · Pettit et al. · 1997 [cited by applicant]
US 5648237A · Carter et al. · 1997 [cited by applicant]
US 5648260A · Winter et al. · 1997 [cited by applicant]
US 5677180A · Robinson et al. · 1997 [cited by applicant]
US 5688651A · Solomon et al. · 1997 [cited by applicant]
US 5712374A · Kuntsmann et al. · 1998 [cited by applicant]
US 5714586A · Kunstmann et al. · 1998 [cited by applicant]
US 5721108A · Robinson et al. · 1998 [cited by applicant]
US 5736137A · Anderson et al. · 1998 [cited by applicant]
US 5739116A · Hamann et al. · 1998 [cited by applicant]
US 5767285A · Hamann et al. · 1998 [cited by applicant]
US 5770429A · Lonberg et al. · 1998 [cited by applicant]
US 5770701A · McGahren et al. · 1998 [cited by applicant]
US 5770710A · McGahren et al. · 1998 [cited by applicant]
US 5773001A · Hamann et al. · 1998 [cited by applicant]
US 5776456A · Anderson et al. · 1998 [cited by applicant]
US 5780588A · Pettit et al. · 1998 [cited by applicant]
US 5789199A · Joly et al. · 1998 [cited by applicant]
US 5821337A · Carter et al. · 1998 [cited by applicant]
US 5840523A · Simmons et al. · 1998 [cited by applicant]
US 5843398A · Kaminski et al. · 1998 [cited by applicant]
US 5843439A · Anderson et al. · 1998 [cited by applicant]
US 5849898A · Seed et al. · 1998 [cited by applicant]
US 5877296A · Hamann et al. · 1999 [cited by applicant]
US 5955317A · Suzuki et al. · 1999 [cited by applicant]
US 5959177A · Hein et al. · 1999 [cited by applicant]
US 6015542A · Kaminski et al. · 2000 [cited by applicant]
US 6015555A · Friden · 2000 [cited by applicant]
US 6040498A · Stomp et al. · 2000 [cited by applicant]
US 6066652A · Zenner et al. · 2000 [cited by applicant]
US 6075181A · Kucherlapati et al. · 2000 [cited by applicant]
US 6083747A · Wong et al. · 2000 [cited by applicant]
US 6090365A · Kaminski et al. · 2000 [cited by applicant]
US 6120767A · Robinson et al. · 2000 [cited by applicant]
US 6150584A · Kucherlapati et al. · 2000 [cited by applicant]
US 6171586B1 · Lam et al. · 2001 [cited by applicant]
US 6194551B1 · Idusogie et al. · 2001 [cited by applicant]
US 6224866B1 · Barbera-Guillem · 2001 [cited by applicant]
US 6242195B1 · Idusogie et al. · 2001 [cited by applicant]
US 6267958B1 · Andya et al. · 2001 [cited by applicant]
US 6287537B1 · Kaminski et al. · 2001 [cited by applicant]
US 6306393B1 · Goldenberg et al. · 2001 [cited by applicant]
US 6368596B1 · Ghetie et al. · 2002 [cited by applicant]
US 6399061B1 · Anderson et al. · 2002 [cited by applicant]
US 6410391B1 · Zelsacher · 2002 [cited by applicant]
US 6417429B1 · Hein et al. · 2002 [cited by applicant]
US 6420548B1 · Vezina et al. · 2002 [cited by applicant]
US 6455043B1 · Grillo-Lopez · 2002 [cited by applicant]
US 6528624B1 · Idusogie et al. · 2003 [cited by applicant]
US 6538124B1 · Idusogie et al. · 2003 [cited by applicant]
US 6565827B1 · Kaminski et al. · 2003 [cited by applicant]
US 6602684B1 · Umana et al. · 2003 [cited by applicant]
US 6630579B2 · Chari et al. · 2003 [cited by applicant]
US 6652852B1 · Robinson et al. · 2003 [cited by applicant]
US 6682734B1 · Anderson et al. · 2004 [cited by applicant]
US 6737056B1 · Presta et al. · 2004 [cited by applicant]
US 6982321B2 · Winter et al. · 2006 [cited by applicant]
US 7041870B2 · Tomizuka et al. · 2006 [cited by applicant]
US 7087409B2 · Barbas et al. · 2006 [cited by applicant]
US 7125978B1 · Vezina et al. · 2006 [cited by applicant]
US 7189826B2 · Rodman · 2007 [cited by applicant]
US 7332581B2 · Presta et al. · 2008 [cited by applicant]
US 7371826B2 · Presta et al. · 2008 [cited by applicant]
US 7498298B2 · Doronina et al. · 2009 [cited by applicant]
US 7521541B2 · Eigenbrot et al. · 2009 [cited by applicant]
US 7527791B2 · Adams et al. · 2009 [cited by applicant]
US 7794719B2 · Bardroff et al. · 2010 [cited by applicant]
US 8883980B2 · Umana et al. · 2014 [cited by applicant]
US 8945867B2 · Ogawa et al. · 2015 [cited by applicant]
US 9598496B2 · Kurosawa et al. · 2017 [cited by applicant]
US 9714292B2 · Auer et al. · 2017 [cited by applicant]
US 10323089B2 · Dengl et al. · 2019 [cited by applicant]
US 10323099B2 · Bruenker et al. · 2019 [cited by applicant]
US 10364292B2 · Rueger et al. · 2019 [cited by applicant]
US 10370692B2 · Kopetzki · 2019 [cited by applicant]
US 10941205B2 · Duerr et al. · 2021 [cited by applicant]
US 11098338B2 · Kopetzki et al. · 2021 [cited by applicant]
US 11584793B2 · Dengl et al. · 2023 [cited by applicant]
US 11603411B2 · Duerr et al. · 2023 [cited by applicant]
US 20010018041A1 · Hanna et al. · 2001 [cited by applicant]
US 20010056066A1 · Bugelski et al. · 2001 [cited by applicant]
US 20020004587A1 · Miller et al. · 2002 [cited by applicant]
US 20020006404A1 · Hanna et al. · 2002 [cited by applicant]
US 20020009427A1 · Wolin et al. · 2002 [cited by applicant]
US 20020009444A1 · Grillo-Lopez et al. · 2002 [cited by applicant]
US 20020012665A1 · Hanna et al. · 2002 [cited by applicant]
US 20020025313A1 · Micklus et al. · 2002 [cited by applicant]
US 20020041847A1 · Goldenberg · 2002 [cited by applicant]
US 20020058029A1 · Hanna et al. · 2002 [cited by applicant]
US 20020127652A1 · Schambye et al. · 2002 [cited by applicant]
US 20020128488A1 · Yamakawa et al. · 2002 [cited by applicant]
US 20020136719A1 · Shenoy et al. · 2002 [cited by applicant]
US 20020164328A1 · Shinkawa et al. · 2002 [cited by applicant]
US 20020197255A1 · Anderson et al. · 2002 [cited by applicant]
US 20020197256A1 · Grewal et al. · 2002 [cited by applicant]
US 20030003097A1 · Reff et al. · 2003 [cited by applicant]
US 20030021781A1 · Anderson et al. · 2003 [cited by applicant]
US 20030026801A1 · Weiner et al. · 2003 [cited by applicant]
US 20030068664A1 · Albitar et al. · 2003 [cited by applicant]
US 20030082172A1 · Anderson et al. · 2003 [cited by applicant]
US 20030095963A1 · Anderson et al. · 2003 [cited by applicant]
US 20030103971A1 · Hariharan et al. · 2003 [cited by applicant]
US 20030115614A1 · Kanda et al. · 2003 [cited by applicant]
US 20030133930A1 · Goldenberg et al. · 2003 [cited by applicant]
US 20030147885A1 · Anderson et al. · 2003 [cited by applicant]
US 20030148404A1 · Michaelson · 2003 [cited by applicant]
US 20030157108A1 · Presta · 2003 [cited by applicant]
US 20030180292A1 · Hanna et al. · 2003 [cited by applicant]
US 20030185796A1 · Wolin et al. · 2003 [cited by applicant]
US 20030202972A1 · Andya et al. · 2003 [cited by applicant]
US 20030219433A1 · Hansen et al. · 2003 [cited by applicant]
US 20030219818A1 · Bohen et al. · 2003 [cited by applicant]
US 20040082762A1 · Basi et al. · 2004 [cited by applicant]
US 20040093621A1 · Shitara et al. · 2004 [cited by applicant]
US 20040109865A1 · Niwa et al. · 2004 [cited by applicant]
US 20040110282A1 · Kanda et al. · 2004 [cited by applicant]
US 20040110704A1 · Yamane et al. · 2004 [cited by applicant]
US 20040131692A1 · Kreuter et al. · 2004 [cited by applicant]
US 20040132140A1 · Satoh et al. · 2004 [cited by applicant]
US 20040180417A1 · Seidah et al. · 2004 [cited by applicant]
US 20040192898A1 · Jia et al. · 2004 [cited by applicant]
US 20040197324A1 · Liu et al. · 2004 [cited by applicant]
US 20040204354A1 · Nelson et al. · 2004 [cited by applicant]
US 20040248197A1 · Holtzman et al. · 2004 [cited by applicant]
US 20050014934A1 · Hinton et al. · 2005 [cited by applicant]
US 20050058644A1 · Engleman · 2005 [cited by applicant]
US 20050123546A1 · Umana et al. · 2005 [cited by applicant]
US 20050142133A1 · Lazar et al. · 2005 [cited by applicant]
US 20050147613A1 · Raso · 2005 [cited by applicant]
US 20050169925A1 · Bardroff et al. · 2005 [cited by applicant]
US 20050180972A1 · Wahl et al. · 2005 [cited by applicant]
US 20050260186A1 · Bookbinder et al. · 2005 [cited by applicant]
US 20060008883A1 · Lazar et al. · 2006 [cited by applicant]
US 20060104968A1 · Bookbinder et al. · 2006 [cited by applicant]
US 20060210557A1 · Luisi et al. · 2006 [cited by applicant]
US 20060251652A1 · Watkins et al. · 2006 [cited by applicant]
US 20070061900A1 · Murphy et al. · 2007 [cited by applicant]
US 20070098721A1 · Heinz et al. · 2007 [cited by applicant]
US 20080167449A1 · Lazar et al. · 2008 [cited by applicant]
US 20080275220A1 · Friess et al. · 2008 [cited by applicant]
US 20090162359A1 · Klein et al. · 2009 [cited by applicant]
US 20090252724A1 · Loetscher et al. · 2009 [cited by applicant]
US 20090263491A1 · Kreuter et al. · 2009 [cited by applicant]
US 20090297436A1 · Garcia-Martinez et al. · 2009 [cited by applicant]
US 20100016786A1 · Drews et al. · 2010 [cited by applicant]
US 20100077498A1 · Pardridge et al. · 2010 [cited by applicant]
US 20100081796A1 · Brinkmann et al. · 2010 [cited by applicant]
US 20100098693A1 · Pardridge et al. · 2010 [cited by applicant]
US 20100121036A1 · Fischer et al. · 2010 [cited by applicant]
US 20100129357A1 · Garcia-Martinez et al. · 2010 [cited by applicant]
US 20100172907A1 · Bardroff et al. · 2010 [cited by applicant]
US 20100190247A1 · Lazar et al. · 2010 [cited by applicant]
US 20100256338A1 · Brinkmann et al. · 2010 [cited by applicant]
US 20100322934A1 · Imhof-Jung et al. · 2010 [cited by applicant]
US 20110070225A1 · Goldbach et al. · 2011 [cited by applicant]
US 20120034160A1 · Ghayur et al. · 2012 [cited by applicant]
US 20120141484A1 · Garcia-Martinez et al. · 2012 [cited by applicant]
US 20120171120A1 · Dennis et al. · 2012 [cited by applicant]
US 20120244577A1 · Dixit et al. · 2012 [cited by applicant]
US 20130034554A1 · Garcia-Martinez et al. · 2013 [cited by applicant]
US 20130039925A1 · Bansal · 2013 [cited by applicant]
US 20130045206A1 · Poul et al. · 2013 [cited by applicant]
US 20130078249A1 · Ast et al. · 2013 [cited by applicant]
US 20130090457A1 · Cunningham et al. · 2013 [cited by applicant]
US 20130136747A1 · Bardroff et al. · 2013 [cited by applicant]
US 20130315901A1 · Derosier et al. · 2013 [cited by applicant]
US 20140114054A1 · Yoshikazu et al. · 2014 [cited by applicant]
US 20140154254A1 · Kannan et al. · 2014 [cited by applicant]
US 20140212423A1 · Karaoglu-Hanzatian et al. · 2014 [cited by applicant]
US 20140271459A1 · Dutzar · 2014 [cited by applicant]
US 20140271464A1 · Garcia-Martinez et al. · 2014 [cited by applicant]
US 20140271661A1 · Ye et al. · 2014 [cited by applicant]
US 20150030589A1 · Goldbach et al. · 2015 [cited by applicant]
US 20150110791A1 · Zhang et al. · 2015 [cited by applicant]
US 20150125446A1 · Klein et al. · 2015 [cited by applicant]
US 20150132217A1 · Chang et al. · 2015 [cited by applicant]
US 20150140003A1 · Kaluza et al. · 2015 [cited by applicant]
US 20150196663A1 · Shusta et al. · 2015 [cited by applicant]
US 20150266947A1 · Sierks · 2015 [cited by applicant]
US 20150315296A1 · Schaefer et al. · 2015 [cited by applicant]
US 20150322149A1 · Bohrmann et al. · 2015 [cited by applicant]
US 20150353639A1 · Watts et al. · 2015 [cited by applicant]
US 20160145348A1 · Stephan · 2016 [cited by applicant]
US 20180171012A1 · Sonoda et al. · 2018 [cited by applicant]
US 20180222992A1 · Duerr et al. · 2018 [cited by applicant]
US 20180222993A1 · Duerr et al. · 2018 [cited by applicant]
US 20180282408A1 · Dengl et al. · 2018 [cited by applicant]
US 20180291110A1 · Klein et al. · 2018 [cited by applicant]
US 20190276530A1 · Bohrmann et al. · 2019 [cited by applicant]
US 20200071413A1 · Rueger et al. · 2020 [cited by applicant]
US 20200216554A1 · Duerr et al. · 2020 [cited by applicant]
US 20220144963A9 · Duerr et al. · 2022 [cited by applicant]
US 20220306761A1 · Duerr et al. · 2022 [cited by applicant]
CL 2014003161A1 · 2015 [cited by applicant]
CL 2015003406A1 · 2016 [cited by applicant]
CL 2017003351A1 · 2018 [cited by applicant]
CL 2017003207A1 · 2018 [cited by applicant]
CL 2018000819A1 · 2018 [cited by applicant]
CN 101061140A · 2007 [cited by applicant]
CN 101842387A · 2010 [cited by applicant]
CN 101245107B · 2010 [cited by applicant]
CN 102740888A · 2012 [cited by applicant]
CN 102741282A · 2012 [cited by applicant]
CN 102933601A · 2013 [cited by applicant]
CN 103534272A · 2014 [cited by applicant]
CO 2017012416A2 · 2018 [cited by applicant]
CO 2018000235A2 · 2018 [cited by applicant]
CO 2018003452A2 · 2018 [cited by applicant]
EP 0332865A2 · 1989 [cited by applicant]
EP 0307434B1 · 1993 [cited by applicant]
EP 0307434B2 · 1993 [cited by applicant]
EP 0683234A1 · 1994 [cited by applicant]
EP 0425235B1 · 1996 [cited by applicant]
EP 0330191B1 · 1996 [cited by applicant]
EP 0340109B1 · 1997 [cited by applicant]
EP 1125905A1 · 2001 [cited by applicant]
EP 2343086A1 · 2011 [cited by applicant]
EP 2668901A1 · 2013 [cited by applicant]
EP 2708560A1 · 2014 [cited by applicant]
EP 2787078A1 · 2014 [cited by applicant]
FR 2953841 · 2009 [cited by applicant]
FR 2953841A1 · 2011 [cited by applicant]
JP 2014506258A · 2014 [cited by applicant]
JP 2015528452A · 2015 [cited by applicant]
JP 2017187722A · 2017 [cited by applicant]
JP 2018516811A · 2018 [cited by applicant]
RU 2439160C1 · 2012 [cited by applicant]
UA 100699C2 · 2013 [cited by applicant]
WO 9008187A1 · 1990 [cited by applicant]
WO 9011294A1 · 1990 [cited by applicant]
WO 91001133A1 · 1991 [cited by applicant]
WO 9103259A1 · 1991 [cited by applicant]
WO 9111520A1 · 1991 [cited by applicant]
WO 9310819A1 · 1993 [cited by applicant]
WO 9321232A1 · 1993 [cited by applicant]
WO 9325673A1 · 1993 [cited by applicant]
WO 9411026A2 · 1994 [cited by applicant]
WO 9411026A3 · 1994 [cited by applicant]
WO 9429351A2 · 1994 [cited by applicant]
WO 9503770A1 · 1995 [cited by applicant]
WO 95015769A1 · 1995 [cited by applicant]
WO 9607321A1 · 1996 [cited by applicant]
WO 96020218A1 · 1996 [cited by applicant]
WO 96025088A1 · 1996 [cited by applicant]
WO 9639628A1 · 1996 [cited by applicant]
WO 9704801A1 · 1997 [cited by applicant]
WO 97008320A1 · 1997 [cited by applicant]
WO 9730087A1 · 1997 [cited by applicant]
WO 9856418A1 · 1998 [cited by applicant]
WO 9858964A1 · 1998 [cited by applicant]
WO 9922764A1 · 1999 [cited by applicant]
WO 9927944A1 · 1999 [cited by applicant]
WO 99051642A1 · 1999 [cited by applicant]
WO 0009160A1 · 2000 [cited by applicant]
WO 0020864A1 · 2000 [cited by applicant]
WO 0023472A2 · 2000 [cited by applicant]
WO 0027428A1 · 2000 [cited by applicant]
WO 0027433A1 · 2000 [cited by applicant]
WO 0042072A2 · 2000 [cited by applicant]
WO 0044788A1 · 2000 [cited by applicant]
WO 0061739A1 · 2000 [cited by applicant]
WO 0061768A1 · 2000 [cited by applicant]
WO 0064482A1 · 2000 [cited by applicant]
WO 0067795A1 · 2000 [cited by applicant]
WO 0067796A1 · 2000 [cited by applicant]
WO 0072880A1 · 2000 [cited by applicant]
WO 0074718A1 · 2000 [cited by applicant]
WO 0076542A1 · 2000 [cited by applicant]
WO 0077178A1 · 2000 [cited by applicant]
WO 0103734A1 · 2001 [cited by applicant]
WO 0110460A1 · 2001 [cited by applicant]
WO 0110461A1 · 2001 [cited by applicant]
WO 0110462A1 · 2001 [cited by applicant]
WO 0113945A1 · 2001 [cited by applicant]
WO 0129246 · 2001 [cited by applicant]
WO 0134194A1 · 2001 [cited by applicant]
WO 0139796A1 · 2001 [cited by applicant]
WO 0172333A1 · 2001 [cited by applicant]
WO 0174388A1 · 2001 [cited by applicant]
WO 0177342A1 · 2001 [cited by applicant]
WO 0180884A1 · 2001 [cited by applicant]
WO 0197858A2 · 2001 [cited by applicant]
WO 0202597A2 · 2002 [cited by applicant]
WO 0204021A1 · 2002 [cited by applicant]
WO 02031140A1 · 2002 [cited by applicant]
WO 0234790A1 · 2002 [cited by applicant]
WO 02096948A2 · 2002 [cited by applicant]
WO 02046237A2 · 2002 [cited by applicant]
WO 02060955A2 · 2002 [cited by applicant]
WO 02064734A2 · 2002 [cited by applicant]
WO 02079255A1 · 2002 [cited by applicant]
WO 02088306A2 · 2002 [cited by applicant]
WO 02088307A2 · 2002 [cited by applicant]
WO 02096937A2 · 2002 [cited by applicant]
WO 02102312A2 · 2002 [cited by applicant]
WO 03002607A1 · 2003 [cited by applicant]
WO 03009817A2 · 2003 [cited by applicant]
WO 03011878A2 · 2003 [cited by applicant]
WO 03016466A2 · 2003 [cited by applicant]
WO 03049694A2 · 2003 [cited by applicant]
WO 03061694A1 · 2003 [cited by applicant]
WO 03068821A2 · 2003 [cited by applicant]
WO 03070760A2 · 2003 [cited by applicant]
WO 03084570A1 · 2003 [cited by applicant]
WO 03085107A1 · 2003 [cited by applicant]
WO 03085119A1 · 2003 [cited by applicant]
WO 2004014953A2 · 2004 [cited by applicant]
WO 2004014953A3 · 2004 [cited by applicant]
WO 2004032828A2 · 2004 [cited by applicant]
WO 2004032868A1 · 2004 [cited by applicant]
WO 2004035607A2 · 2004 [cited by applicant]
WO 2004056312A2 · 2004 [cited by applicant]
WO 2004103404A1 · 2004 [cited by applicant]
WO 2005035586A1 · 2005 [cited by applicant]
WO 2005035778A1 · 2005 [cited by applicant]
WO 2005053742A1 · 2005 [cited by applicant]
WO 2005116220A1 · 2005 [cited by applicant]
WO 2005092925A3 · 2005 [cited by applicant]
WO 2005100402A1 · 2005 [cited by applicant]
WO 2006029879A2 · 2006 [cited by applicant]
WO 2006029879A3 · 2006 [cited by applicant]
WO 2006030220 · 2006 [cited by applicant]
WO 2006044908A2 · 2006 [cited by applicant]
WO 2006081587A2 · 2006 [cited by applicant]
WO 2006083689A2 · 2006 [cited by applicant]
WO 2006131013A2 · 2006 [cited by applicant]
WO 2007044323A2 · 2007 [cited by applicant]
WO 2007044323A3 · 2007 [cited by applicant]
WO 2007068429A1 · 2007 [cited by applicant]
WO 2007110152A2 · 2007 [cited by applicant]
WO 2007110339A1 · 2007 [cited by applicant]
WO 2007143711A2 · 2007 [cited by applicant]
WO 2008005847A2 · 2008 [cited by applicant]
WO 2008022349A2 · 2008 [cited by applicant]
WO 2008022349A3 · 2008 [cited by applicant]
WO 2008025527A1 · 2008 [cited by applicant]
WO 2008039944A2 · 2008 [cited by applicant]
WO 2008063771 · 2008 [cited by applicant]
WO 2008071394A1 · 2008 [cited by applicant]
WO 2008077546A1 · 2008 [cited by applicant]
WO 2009018411 · 2009 [cited by applicant]
WO 2009040562A1 · 2009 [cited by applicant]
WO 2009126616A2 · 2009 [cited by applicant]
WO 2010033587A2 · 2010 [cited by applicant]
WO 2010102251A2 · 2010 [cited by applicant]
WO 2010115551 · 2010 [cited by applicant]
WO 2010115553A1 · 2010 [cited by applicant]
WO 2011066369A2 · 2011 [cited by applicant]
WO 2011066371A2 · 2011 [cited by applicant]
WO 2011073943A1 · 2011 [cited by applicant]
WO 2011116387A1 · 2011 [cited by applicant]
WO 2011130377A2 · 2011 [cited by applicant]
WO 2012075037A1 · 2012 [cited by applicant]
WO 2012087835A2 · 2012 [cited by applicant]
WO 2012088247A2 · 2012 [cited by applicant]
WO 2012093125A1 · 2012 [cited by applicant]
WO 2012096924A1 · 2012 [cited by applicant]
WO 2012130831A1 · 2012 [cited by applicant]
WO 2012143379A1 · 2012 [cited by applicant]
WO 2012153707A1 · 2012 [cited by applicant]
WO 2013006244A1 · 2013 [cited by applicant]
WO 2013012733A1 · 2013 [cited by applicant]
WO 2013025853A1 · 2013 [cited by applicant]
WO 2013026831A1 · 2013 [cited by applicant]
WO 2013038156A1 · 2013 [cited by applicant]
WO 2013039471A1 · 2013 [cited by applicant]
WO 2013079174A1 · 2013 [cited by applicant]
WO 2013113615A1 · 2013 [cited by applicant]
WO 2013127816A1 · 2013 [cited by applicant]
WO 2013131866A1 · 2013 [cited by applicant]
WO 2013177062A2 · 2013 [cited by applicant]
WO 2013177062A3 · 2013 [cited by applicant]
WO 2014033074A1 · 2014 [cited by applicant]
WO 2014039855A1 · 2014 [cited by applicant]
WO 2014047231A1 · 2014 [cited by applicant]
WO 2014052188A1 · 2014 [cited by applicant]
WO 2014081955A1 · 2014 [cited by applicant]
WO 2014082179A1 · 2014 [cited by applicant]
WO 2014089209A3 · 2014 [cited by applicant]
WO 2014131694A1 · 2014 [cited by applicant]
WO 2014131711A1 · 2014 [cited by applicant]
WO 2014153114A1 · 2014 [cited by applicant]
Cited By (2)
US 12,358,997 US 12,735,497